SCHEMBL107527

SCHEMBL107527

O=C(OCc1ccccc1-c1ccc(C(F)(F)F)cc1)ON1CCN(CCC(=O)c2ccc3[nH]c(=O)oc3c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 9/20 0.54
KCNH2 Q12809 2/20 0.49
GRIN2B Q13224 2/20 0.45
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
ATXN2 Q99700 2/20 0.44
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
FFAR1 O14842 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
TRPV1 Q8NER1 2/20 0.34
CETP P11597 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL107526 0.90 ENPP2 (0.68) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL105919 0.82 ENPP2 (0.77) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL15135290 0.79 ENPP2 (0.48) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL105610 0.78 ENPP2 (0.54) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL104926 0.78 ENPP2 (0.67) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL3050108 0.77 ENPP2 (0.79) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL108790 0.77 ENPP2 (0.58) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL3047548 0.76 ENPP2 (0.68) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL3058061 0.76 ENPP2 (0.67) ENPP2KCNH2GRIN2BGRIN2DGRIN3B
SCHEMBL105676 0.76 ENPP2 (0.62) ENPP2KCNH2GRIN2BGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP claimed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP claimed
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP disclosed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP disclosed